Brooks Lab Share Price Target Tomorrow 2025 To 2030- Market Overview, Financials

Brooks Laboratories Ltd is a pharmaceutical company specializing in the manufacturing and development of a wide range of drugs, including antibiotics, anti-inflammatory, and other therapeutic categories. Known for its state-of-the-art facilities and focus on quality, the company caters to both domestic and international markets. Brooks Lab Share Price on NSE as of 7 January 2025 is 193.45 INR. Here will provide you more details on Brooks Lab Share Price Target 2025, 2026 to 2030.

Brooks Laboratories Ltd: Market Overview

• Open: ₹198.86
• High: ₹198.86
• Low: ₹193.45
• Previous Close: ₹194.97
• Volume: 59,970
• Value (Lacs): ₹116.01
• VWAP: ₹197.47
• UC Limit: ₹198.86
• LC Limit: ₹191.07
• 52 Week High: ₹198.86
• 52 Week Low: ₹73.25
• Mkt Cap (Rs. Cr.): ₹507
• Face Value: ₹10

Brooks Lab Share Price Chart

Brooks Lab Share Price Target Tomorrow 2025 To 2030

Brooks Lab Share Price Target 2025

Brooks Lab share price target 2025 Expected target could be ₹200. Here are 4 Key Factors Affecting Growth for “Brooks Lab Share Price Target 2025”:

• Expansion in Domestic and International Markets: Brooks Laboratories’ ability to increase its presence in untapped markets and strengthen its foothold in existing ones will significantly influence its growth trajectory.
• New Product Launches: Introducing innovative pharmaceutical products and expanding its therapeutic portfolio could enhance revenue streams and market competitiveness.
• Regulatory Approvals: Securing timely approvals from regulatory bodies for new drugs and manufacturing facilities will be a crucial growth driver.

• Focus on Contract Manufacturing: Increasing collaborations with global pharmaceutical companies for contract manufacturing and research services could provide additional revenue and improve operational efficiency.

Brooks Lab Share Price Target 2030

Brooks Lab share price target 2030 Expected target could be ₹350. Here are 4 Risks and Challenges for “Brooks Lab Share Price Target 2030”:

• Regulatory Risks: Brooks Laboratories may face challenges in obtaining approvals for new products or maintaining compliance with evolving regulatory requirements, which can delay product launches and affect market access.
• Intense Competition: The pharmaceutical industry is highly competitive, and Brooks Laboratories may struggle to differentiate itself from established players and new entrants, putting pressure on pricing and margins.
• Raw Material and Supply Chain Disruptions: Any disruptions in the supply chain, particularly in sourcing raw materials, could increase production costs and affect the timely delivery of products to the market.

• Technological Advancements: Rapid changes in pharmaceutical technologies or innovations in drug development by competitors could pose a challenge, requiring continuous investment in R&D to stay relevant.

Brooks Laboratories Ltd Shareholding Pattern

• Promoters: 63.59%
• FII: 0.02%
• DII: 3.86%
• Public: 32.53%

Brooks Laboratories Ltd Financials

Read Also:- Sunflag Iron Share Price Target Tomorrow 2025 To 2030- Market Overview, Financials